Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06628349 · ClinicalTrials.gov registry record · NA

Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

A NA study of Protein Metabolism, sponsored by Texas A&M University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06628349: Recruiting NA study of Protein Metabolism, sponsored by Texas A&M University.

NCT06628349 is a NA study of Protein Metabolism that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 100 participants, above the 32-participant average among 5 other Protein Metabolism trials with a reported enrollment target (213% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06628349, a NA study of Protein Metabolism, is actively recruiting participants, sponsored by Texas A&M University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The researchers overall objective is to determine whether plant and animal protein based proteins affect the anabolic responses across aging populations differently due to specific changes in the essential amino acids (EAA) and non-essential amino acids (NEAA) kinetic responses. The researchers central hypothesis is that a high EAA to NEAA ratio in a protein meal is related to higher anabolic response to the meal. The researchers also hypothesize that the type of NEAA in a protein meal also affects the anabolic capacity of the meal. The researchers rationale is that finding the amino acid composition of a meal that will maximally induce protein anabolism will guide novel nutritional approaches to prevent and treat sarcopenia, thereby reducing both overall economic burden and improving individual patient outcomes.

Primary Outcome

A novel stable isotope technique will be used to assess simultaneously the anabolic response and whole body production rates of a variety of amino acids to intake of both dietary proteins in sarcopenic older participants. The samples will be stored in laboratory freezers and the amino acid isotope enrichments and concentrations analyzed by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). The researchers will then conduct LC-MS/MS analysis, peak integration, calculation of amino ac

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey Protein Isolate 90%
  • DIETARY_SUPPLEMENT Soy Protein Isolate (90% Protein)
  • DIETARY_SUPPLEMENT Organic Pea Protein Isolate
  • DIETARY_SUPPLEMENT Placebo (Water)

Study Locations (1)

Texas

  • Texas A&M University - CTRAL - College Station

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-02-01
Est. Completion 2026-12
Phase NA
Texas A&M University

95 total trials

What NCT06628349 shows while recruiting

NCT06628349 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 32-participant average among 5 other Protein Metabolism trials with a reported enrollment target (213% higher).

The record links to 1 condition, with Protein Metabolism appearing as the primary indexed condition, and to 4 interventions - of which Whey Protein Isolate 90% is the first listed.

NCT06628349 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06628349 about?

NCT06628349 is a clinical study titled "Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein". The researchers overall objective is to determine whether plant and animal protein based proteins affect the anabolic responses across aging populations differently due to specific changes in the essential amino acids (EAA) and non-essential amino acids (NEAA) kinetic responses. The researchers cent...

What is the current status of trial NCT06628349?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-02-01. Estimated completion is 2026-12.

What conditions does trial NCT06628349 study?

This clinical trial studies the following conditions: Protein Metabolism.

What interventions are being tested in trial NCT06628349?

The interventions under investigation include: Whey Protein Isolate 90% (DIETARY_SUPPLEMENT), Soy Protein Isolate (90% Protein) (DIETARY_SUPPLEMENT), Organic Pea Protein Isolate (DIETARY_SUPPLEMENT), Placebo (Water) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06628349?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06628349 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Protein Metabolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06628349, the US trial registry maintained by the National Library of Medicine. NCT06628349 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.